Singla, Nirmish
Nirschl, Thomas R.
Obradovic, Aleksandar Z.
Shenderov, Eugene
Lombardo, Kara
Liu, Xiaopu
Pons, Alice
Zarif, Jelani C.
Rowe, Steven P.
Trock, Bruce J.
Hammers, Hans J.
Bivalacqua, Trinity J.
Pierorazio, Phillip M.
Deutsch, Julie S.
Lotan, Tamara L.
Taube, Janis M.
Ged, Yasser M. A.
Gorin, Michael A.
Allaf, Mohamad E.
Drake, Charles G.
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 25 July 2023
Accepted: 10 January 2024
First Online: 17 January 2024
Competing interests
: Financial disclosures: Nirmish Singla certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g. employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Steven P. Rowe: research funding and consulting agreement with Progenics Pharmaceuticals, Inc., Precision Molecular, Inc., PlenaryAI, Inc.; stock options in D&D Pharmatech. Hans J. Hammers: paid consultant/advisor for ARMO Biosciences, Inc., Bayer AG, Bristol-Myers Squibb, Corvus Pharmaceuticals, Exelixis, Inc., Eli Lilly and Company, Merck & Co., Inc., Pfizer, Inc., Novartis International AG, and Surface Oncology, Inc.; research/grant support from Bristol-Myers Squibb and Merck & Co., Inc. Tamara L. Lotan: research funding from DeepBio, AIRA Matrix and Exact Sciences. Janis M. Taube: paid consultant/advisor for Akoya Biosciences, Inc., AstraZeneca, plc., Bristol-Myers Squibb, Compugen, Ltd., and Merck & Co., Inc.; equipment loan, reagent provision, and stock options with Akoya Biosciences, Inc. Yasser M. A. Ged: advisory board consultation fees from Bristol Meyer Squib, Exelixis, BostonGene, and Aveo. Michael A. Gorin: consultant for RSIP Vision, Corbin Clinical Resources (Perineologic), Blue Earth Diagnostics Limited, KOELIS, Inc., Point Biopharma, Merck, Ambu A/S; speakers bureau and consult for Lantheus Holdings, Inc.; patent licenses for Precision Molecular. Charles G. Drake: employment at Janssen Pharmaceuticals, Inc.